Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation

被引：19

作者：

Howard, Jason D. ^{[1
]}

Lu, Bo ^{[2
]}

Chung, Christine H. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA

[2] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA

来源：

ORAL ONCOLOGY | 2012年 / 48卷 / 01期

关键词：

HNSCC; Targeted therapies; EGFR; PIK3CA; TP53; P16; TGF-beta; NF-kappa B; Notch1; HPV; GENE COPY NUMBER; FACTOR-KAPPA-B; BETA SIGNALING PATHWAY; IN-SITU HYBRIDIZATION; HUMAN-PAPILLOMAVIRUS; PLUS CETUXIMAB; TUMOR-SUPPRESSOR; MUTANT P53; C-MET; CANCER;

D O I：

10.1016/j.oraloncology.2011.09.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Head and neck squamous cell carcinoma (HNSCC) encompasses a diverse group of malignancies originating in the oral cavity, oropharynx, larynx and hypopharynx. Although treatment modalities have improved, carefully designed biomarker-driven clinical trials will yield the best opportunities to enhance HNSCC therapy options in the future. Due to the heterogeneous nature of HNSCC, discovering a "silver bullet" for the treatment of HNSCC is unlikely. Consequently, impactful HNSCC clinical trials will require multiple assay platforms and expanded technical expertise. In this review, we will outline pathways critical to HNSCC oncogenesis and highlight signaling nodes within these pathways that represent biomarkers for prognosis and potential targeted therapies. All treatment modalities are subject to mechanisms of resistance; thus, lessons learned from HNSCC investigations and studies of similar targeted agents in other pertinent malignancies will be discussed. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：10 / 17

页数：8

共 92 条

[1] Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 [J].

Agrawal, Nishant ;

Frederick, Mitchell J. ;

Pickering, Curtis R. ;

Bettegowda, Chetan ;

Chang, Kyle ;

Li, Ryan J. ;

Fakhry, Carole ;

Xie, Tong-Xin ;

Zhang, Jiexin ;

Wang, Jing ;

Zhang, Nianxiang ;

El-Naggar, Adel K. ;

Jasser, Samar A. ;

Weinstein, John N. ;

Trevino, Lisa ;

Drummond, Jennifer A. ;

Muzny, Donna M. ;

Wu, Yuanqing ;

Wood, Laura D. ;

Hruban, Ralph H. ;

Westra, William H. ;

Koch, Wayne M. ;

Califano, Joseph A. ;

Gibbs, Richard A. ;

Sidransky, David ;

Vogelstein, Bert ;

Velculescu, Victor E. ;

Papadopoulos, Nickolas ;

Wheeler, David A. ;

Kinzler, Kenneth W. ;

Myers, Jeffrey N. .

SCIENCE, 2011, 333 (6046) :1154-1157

[2] Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array [J].

Ahrendt, SA ;

Halachmi, S ;

Chow, JT ;

Wu, L ;

Halachmi, N ;

Yang, SC ;

Wehage, S ;

Jen, J ;

Sidransky, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7382-7387

[3] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].

Ang, K. Kian ;

Harris, Jonathan ;

Wheeler, Richard ;

Weber, Randal ;

Rosenthal, David I. ;

Nguyen-Tan, Phuc Felix ;

Westra, William H. ;

Chung, Christine H. ;

Jordan, Richard C. ;

Lu, Charles ;

Kim, Harold ;

Axelrod, Rita ;

Silverman, C. Craig ;

Redmond, Kevin P. ;

Gillison, Maura L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35

[4]

[Anonymous], CLIN TRIALS FDA APPR

[5]

[Anonymous], J CELL PHYSL

[6]

[Anonymous], INT J RAD ONCOL BIOL

[7]

[Anonymous], CANC EPIDEMIOL BIOMA

[8]

Balz V, 2003, CANCER RES, V63, P1188

[9] The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α [J].

Barnard, P ;

Payne, E ;

McMillan, NAJ .

VIROLOGY, 2000, 277 (02) :411-419

[10] Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity [J].

Basu, D. ;

Nguyen, T-T K. ;

Montone, K. T. ;

Zhang, G. ;

Wang, L-P ;

Diehl, J. A. ;

Rustgi, A. K. ;

Lee, J. T. ;

Weinstein, G. S. ;

Herlyn, M. .

ONCOGENE, 2010, 29 (29) :4170-4182

← 1 2 3 4 5 6 7 8 9 10 →